{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:32:44Z","timestamp":1790458364940,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Visiting Researcher Program at Kyoto University Research Reactor","award":["25293267"],"award-info":[{"award-number":["25293267"]}]},{"name":"Japanese Ministry of Science, Culture and Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,16]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Our aim was to assess the long-term clinical outcome of boron neutron capture therapy (BNCT) using 10B-para-boronophenylalanine (BPA) as the boron delivery agent for cutaneous melanoma. Eight patients (eight lesions) were treated between October 2003 and April 2014. Their ages ranged from 48 to 86\u00a0years at the time of treatment. All of the targets were primary lesions and they were located on the sole or face. No patient had evidence of regional lymph node involvement, distant metastases or an active secondary cancer. The clinical stage was cT1-2N0M0 and performance scores were &amp;lt;2. BNCT was carried out at the Kyoto University Research Reactor (KUR). The patients were irradiated with an epithermal neutron beam between the curative tumor dose and the tolerable skin dose. Eight patients were evaluated and six showed a complete response (CR), while two patients had a partial response (PR). Of the two patients with a PR, one has remained a PR with brown spots persisting for 7.5\u00a0years following BNCT. The tumor in the other patient recurred after 6\u00a0years at the site of persisting brown macula. The overall control rate (CR\u00a0+\u00a0PR without recurrence) for the cohort was 88% (7\/8). There have never been any adverse events &amp;gt;Grade 2 for the long follow-up period. Our results suggest that BNCT may be a promising treatment modality in the management of early stage cutaneous melanoma when wide local excision is not feasible.<\/jats:p>","DOI":"10.1093\/jrr\/rraa068","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T07:44:25Z","timestamp":1600847065000},"page":"945-951","source":"Crossref","is-referenced-by-count":69,"title":["Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)"],"prefix":"10.1093","volume":"61","author":[{"given":"Junichi","family":"Hiratsuka","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kamitani","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Tokiya","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Yoden","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosinori","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Particle Radiation Oncology, Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Particle Radiation Oncology, Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"2021032415524830300_ref1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bjps.2007.12.050","article-title":"Flap reconstruction following gynaecological tumour resection for advanced and recurrent disease--a 12year experience","volume":"62","author":"Staiano","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2021032415524830300_ref2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined Nivolumab and Ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"2021032415524830300_ref3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2013.02.028","article-title":"Vulvar and vaginal melanoma: Case series and review of current management options including neoadjuvant chemotherapy","volume":"129","author":"Janco","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2021032415524830300_ref4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jrr\/rrt120","article-title":"Clinical trial of carbon ion radiotherapy for gynecological melanoma","volume":"55","author":"Karasawa","year":"2014","journal-title":"J Radiat Res"},{"key":"2021032415524830300_ref5","first-page":"215","volume-title":"Pigment Cell, vol 1, Mechanisms in Pigmentation","author":"Mishima","year":"1973"},{"key":"2021032415524830300_ref6","first-page":"55","volume-title":"Neutron Capture Therapy. Niigata","author":"Yoshino","year":"1986"},{"key":"2021032415524830300_ref7","first-page":"167","article-title":"RBE of a thermal neutron beam and the 10B(n, \u03b1)7Li reaction on cultured B-16 melanoma cells","volume":"51","author":"Fukuda","year":"1987","journal-title":"Int J Radiat Biol"},{"key":"2021032415524830300_ref8","first-page":"127","article-title":"Improvement of solubility of p-boronophenylalanine by complex formation with monosaccarides","volume":"165","author":"Yoshino","year":"1989","journal-title":"Strahlenther Onkol"},{"key":"2021032415524830300_ref9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0749.1989.tb00219.x","article-title":"RBEs of thermal neutron capture therapy and 10B (n, \u03b1) 7Li reaction on melanoma-bearing hamsters","volume":"2","author":"Hiratsuka","year":"1989","journal-title":"Pigment Cell Res"},{"key":"2021032415524830300_ref10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0749.1989.tb00196.x","article-title":"New thermal neutron capture therapy for malignant melanoma: Melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial","volume":"2","author":"Mishima","year":"1989","journal-title":"Pigment Cell Res"},{"key":"2021032415524830300_ref11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(89)90567-9","article-title":"Treatment of malignant melanoma by single neutron capture treatment with melanoma-seeking 10B-compound","volume":"2","author":"Mishima","year":"1989","journal-title":"Lancet"},{"key":"2021032415524830300_ref12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2307\/3578136","article-title":"The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster","volume":"128","author":"Hiratsuka","year":"1991","journal-title":"Radiat Res"},{"key":"2021032415524830300_ref13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2307\/3578693","article-title":"Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin","volume":"138","author":"Fukuda","year":"1994","journal-title":"Radiat Res"},{"key":"2021032415524830300_ref14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF03178777","article-title":"Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor","volume":"26","author":"Fukuda","year":"2003","journal-title":"Australas Phys Eng Sci Med"},{"key":"2021032415524830300_ref15","first-page":"60","volume-title":"Advances in Neutron Capture Therapy, Volume I","author":"Busse","year":"1997"},{"key":"2021032415524830300_ref16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0360-3016(02)02862-6","article-title":"Treatment planning and dosimetry for the Harvard-MIT PhaseII clinical trial of cranial neutron capture therapy","volume":"53","author":"Palmer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021032415524830300_ref17","first-page":"284","volume-title":"Advances in Neutron Capture Therapy 2006","author":"Wittig","year":"2006"},{"key":"2021032415524830300_ref18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.apradiso.2004.05.060","article-title":"First BNCT treatment of a skin melanoma in Argentina: Dosimetric analysis and clinical outcome","volume":"61","author":"Gonzales","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"2021032415524830300_ref19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.21147\/j.issn.1000-9604.2016.06.10","article-title":"Boron neutron capture therapy for malignant melanoma: First clinical case report in China","volume":"28","author":"Yong","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"2021032415524830300_ref20","first-page":"18","author":"Morita","year":"2006"},{"key":"2021032415524830300_ref21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0167-5087(83)90082-0","article-title":"Microanalysis system of ppm-order 10b concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry","volume":"204","author":"Kobayashi","year":"1983","journal-title":"Nucl Instrum Methods Phys Res A"},{"key":"2021032415524830300_ref22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00008390-199902000-00010","article-title":"Pharmacokinetics of 10B-p-boronophenylalanine in tumors, skin and blood of melanoma patients: A study of boron neutron capture therapy for malignant melanoma","volume":"9","author":"Fukuda","year":"1999","journal-title":"Melanoma Res"},{"key":"2021032415524830300_ref23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0167-8140(94)90101-5","article-title":"Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium","volume":"32","author":"Morris","year":"1994","journal-title":"Radiother Oncol"},{"key":"2021032415524830300_ref24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jrr\/rrt098","article-title":"Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer","volume":"55","author":"Suzuki","year":"2014","journal-title":"J Radiat Res"},{"key":"2021032415524830300_ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3579742","article-title":"Review; the radiation biology of boron neutron capture therapy","volume":"151","author":"Coderre","year":"1999","journal-title":"Radiat Res"},{"key":"2021032415524830300_ref26","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.apradiso.2011.04.019","article-title":"The radiobiological principles of boron neutron capture therapy; a critical review","volume":"69","author":"Hopewell","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"2021032415524830300_ref27","first-page":"66","article-title":"Sera -- an advanced treatment planning system for neutron therapy and bnct","volume":"10","author":"Nigg","year":"1999","journal-title":"Trans Am Nucl Soc"},{"key":"2021032415524830300_ref28","first-page":"1643","volume-title":"Cancer: Principles and Practice of Oncology","author":"Slingluff","year":"2011"},{"key":"2021032415524830300_ref29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0360-3016(94)90197-X","article-title":"Neutron brachytherapy in the treatment of melanoma","volume":"28","author":"Vtyurin","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021032415524830300_ref30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jjco\/hys104","article-title":"A review of update clinical results of carbon ion radiotherapy","volume":"42","author":"Tsuji","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"2021032415524830300_ref31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2016.12.028","article-title":"Multicenter study of carbon-ion radiation therapy for mucosal melanoma of the head and neck: Subanalysis of the Japan carbon-ion radiation oncology study group (J-CROS) study (1402HN)","volume":"97","author":"Kato","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021032415524830300_ref32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2015.10.025","article-title":"Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or Para-nasal sinuses","volume":"118","author":"Zenda","year":"2016","journal-title":"Radiother Oncol"},{"key":"2021032415524830300_ref33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000246687","article-title":"Proton radiotherapy for malignant melanoma of the skin","volume":"190","author":"Umebayashi","year":"1995","journal-title":"Dermatology"},{"key":"2021032415524830300_ref34","first-page":"234","volume-title":"Advances in neutron capture therapy","author":"Yoshino","year":"1997"},{"key":"2021032415524830300_ref35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0749.1998.tb00736.x","article-title":"Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma","volume":"11","author":"Tsuboi","year":"1998","journal-title":"Pigment Cell Res"},{"key":"2021032415524830300_ref36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-017-0458-3","article-title":"The use of immunotherapy in the treatment of melanoma","volume":"10","author":"Achkar","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2021032415524830300_ref37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/cco.2017.04.01","article-title":"Immunotherapy of patients with metastatic melanoma","volume":"6","author":"Yu","year":"2017","journal-title":"Chin Clin Oncol"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jrr\/article-pdf\/61\/6\/945\/36685396\/rraa068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jrr\/article-pdf\/61\/6\/945\/36685396\/rraa068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T11:59:59Z","timestamp":1616587199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/61\/6\/945\/5912766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,9,29]]},"published-print":{"date-parts":[[2020,11,16]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rraa068","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,9,29]]}}}